Valuation: Medios AG

Market Cap 248M 278M 230M 208M 390M 26.44B 396M 2.77B 1.09B 13.83B 1.04B 1.02B 43.78B P/E 2026 *
12.1x
P/E 2027 * 8.45x
Enterprise Value 344M 385M 319M 289M 540M 36.65B 549M 3.84B 1.52B 19.17B 1.45B 1.42B 60.7B EV / Sales 2026 *
0.16x
EV / Sales 2027 * 0.14x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day+1.18%
1 week-2.49%
Current month-8.78%
1 month-7.12%
3 months-16.14%
6 months-23.92%
Current year-29.70%
1 week 10.02
Extreme 10.02
10.5
1 month 10.02
Extreme 10.02
11.52
Current year 9.98
Extreme 9.98
17.44
1 year 9.98
Extreme 9.98
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
12/8/26 Buy

Chief Financial Officer

3,500 0.0137%
4/2/26 Sell

Chief Executive Officer

13,638 0.0535%
22/1/26 Buy

Executive/Senior Manager

4,000 0.0157%
Change 5-day change 1-year change 3-year change Capi.($)
+1.18%-2.49%-19.84%-31.12% 278M
+0.45%+3.13%+54.96%+125.16% 1,140B
+0.94%+4.93%+39.86%+78.72% 641B
+0.39%+1.44%+25.77%+97.48% 507B
-0.04%+1.72%+48.32%+66.81% 383B
-3.21%-2.10%+60.72%+33.22% 347B
+1.18%+2.34%+25.49%+54.56% 293B
-0.14%+1.93%+2.52%+27.04% 266B
+1.22%+4.63%+52.40%+64.85% 240B
+1.70%+3.67%+31.21%+102.15% 197B
Average +0.55%+2.57%+32.14%+61.89% 401.41B
Weighted average by Cap. +0.35%+2.98%+41.78%+84.33%

Financials

2026 *2027 *
Net sales 2.17B 2.42B 2.01B 1.82B 3.4B 231B 3.45B 24.13B 9.55B 121B 9.1B 8.9B 382B 2.25B 2.51B 2.08B 1.88B 3.52B 239B 3.58B 25.01B 9.89B 125B 9.43B 9.23B 396B
Net income 20.76M 23.22M 19.21M 17.39M 32.55M 2.21B 33.09M 231M 91.44M 1.16B 87.15M 85.29M 3.66B 29.51M 33M 27.3M 24.72M 46.26M 3.14B 47.02M 329M 130M 1.64B 124M 121M 5.2B
Net Debt 96M 107M 88.82M 80.42M 151M 10.21B 153M 1.07B 423M 5.34B 403M 394M 16.92B 56.62M 63.32M 52.38M 47.43M 88.76M 6.02B 90.22M 630M 249M 3.15B 238M 233M 9.98B
Projected Income Statement - Annual - Medios AG
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
989
Date Price Change Volume
27/10/26 €10.18 +0.39% 5,673
26/10/26 €10.14 +0.20% 15,068
23/10/26 €10.12 -0.78% 8,920
22/10/26 €10.20 -1.92% 24,384
21/10/26 €10.40 -0.38% 3,554
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medios AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.14EUR
Average target price
20.25EUR
Spread / Average Target
+99.70%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Medios AG
  1. Stock Market
  2. Stocks
  3. ILM1 Stock